AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 201 filers reported holding AMICUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,674,262 | +16.3% | 137,686 | +20.1% | 0.00% | 0.0% |
| Q2 2023 | $1,439,841 | +13.0% | 114,637 | -0.2% | 0.00% | 0.0% |
| Q1 2023 | $1,273,886 | -18.6% | 114,868 | -10.4% | 0.00% | 0.0% |
| Q4 2022 | $1,565,493 | +107.9% | 128,214 | +77.6% | 0.00% | 0.0% |
| Q3 2022 | $753,000 | -5.4% | 72,180 | -2.7% | 0.00% | 0.0% |
| Q2 2022 | $796,000 | +7.7% | 74,207 | -5.0% | 0.00% | – |
| Q1 2022 | $739,000 | -16.6% | 78,082 | +1.7% | 0.00% | -100.0% |
| Q4 2021 | $886,000 | -14.4% | 76,748 | -29.2% | 0.00% | 0.0% |
| Q3 2021 | $1,035,000 | +5.1% | 108,372 | +6.0% | 0.00% | 0.0% |
| Q2 2021 | $985,000 | -11.8% | 102,201 | -9.6% | 0.00% | 0.0% |
| Q1 2021 | $1,117,000 | -59.4% | 113,060 | -5.2% | 0.00% | -50.0% |
| Q4 2020 | $2,754,000 | +111.2% | 119,264 | +29.1% | 0.00% | +100.0% |
| Q3 2020 | $1,304,000 | -11.0% | 92,369 | -5.0% | 0.00% | 0.0% |
| Q2 2020 | $1,465,000 | +121.0% | 97,184 | +35.3% | 0.00% | 0.0% |
| Q1 2020 | $663,000 | -3.6% | 71,829 | +1.7% | 0.00% | 0.0% |
| Q4 2019 | $688,000 | +22.6% | 70,659 | +0.9% | 0.00% | – |
| Q3 2019 | $561,000 | -29.1% | 70,021 | +10.5% | 0.00% | -100.0% |
| Q2 2019 | $791,000 | +7.2% | 63,348 | +16.8% | 0.00% | 0.0% |
| Q1 2019 | $738,000 | +47.0% | 54,227 | +3.5% | 0.00% | 0.0% |
| Q4 2018 | $502,000 | -74.0% | 52,407 | -67.1% | 0.00% | -50.0% |
| Q3 2018 | $1,929,000 | -17.0% | 159,501 | +7.3% | 0.00% | 0.0% |
| Q2 2018 | $2,323,000 | +14.7% | 148,699 | +10.4% | 0.00% | 0.0% |
| Q1 2018 | $2,025,000 | +12.1% | 134,648 | +7.2% | 0.00% | 0.0% |
| Q4 2017 | $1,807,000 | +437.8% | 125,621 | +464.1% | 0.00% | – |
| Q3 2017 | $336,000 | +26.8% | 22,270 | -15.2% | 0.00% | – |
| Q2 2017 | $265,000 | +38.0% | 26,269 | -2.3% | 0.00% | – |
| Q1 2017 | $192,000 | +46.6% | 26,883 | +1.8% | 0.00% | – |
| Q4 2016 | $131,000 | -22.0% | 26,396 | +16.2% | 0.00% | – |
| Q3 2016 | $168,000 | +37.7% | 22,718 | +1.4% | 0.00% | – |
| Q2 2016 | $122,000 | -28.7% | 22,411 | +10.5% | 0.00% | – |
| Q1 2016 | $171,000 | -12.3% | 20,289 | +0.7% | 0.00% | – |
| Q4 2015 | $195,000 | -28.8% | 20,149 | +2.8% | 0.00% | – |
| Q3 2015 | $274,000 | +33.0% | 19,609 | +34.9% | 0.00% | – |
| Q2 2015 | $206,000 | – | 14,537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |